5th December 2019
Runtime 23:59
Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, filmed by London South East on behalf of Hardman.
Open Orphan #ORPH was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise. Open Orphan is listed on both the London and Dublin stock exchanges.
